ArticleFrontiers in cell and developmental biology2020

No Impact of Long-Term Fingolimod Treatment on Fecal Secretory Immunoglobulin A Levels in Patients With Multiple Sclerosis.

Hernan Inojosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.